Jordan Julie 4
4 · Homology Medicines, Inc. · Filed Aug 4, 2023
Insider Transaction Report
Form 4
Jordan Julie
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2023-08-02+350→ 2,869 total - Sale
Common Stock
2023-08-02$1.31/sh−99$130→ 2,770 total - Exercise/Conversion
Restricted Stock Units
2023-08-02−350→ 0 total→ Common Stock (350 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.
- [F2]The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on September 14, 2021 solely with the intent to cover taxes in connection with the vesting of certain previously reported restricted stock units.
- [F3]The restricted stock units vested and settled in full on August 2, 2023.